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Abstract
The Cancer Prevention and Control Research Network (CPCRN) is a thematic network dedicated 
to accelerating the adoption of evidence-based cancer prevention and control practices in 
communities by advancing dissemination and implementation science. Funded by the Centers for 
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Disease Control and Prevention and National Cancer Institute, CPCRN has operated at two levels: 
Each participating Network Center conducts research projects with primarily local partners as well 
as multicenter collaborative research projects with state and national partners. Through multicenter 
collaboration, thematic networks leverage the expertise, resources, and partnerships of 
participating centers to conduct research projects collectively that might not be feasible 
individually. Although multicenter collaboration often is advocated, it is challenging to promote 
and assess. Using bibliometric network analysis and other graphical methods, this paper describes 
CPCRN’s multicenter publication progression from 2004 to 2014. Searching PubMed, Scopus, 
and Web of Science in 2014 identified 249 peer-reviewed CPCRN publications involving two or 
more centers out of 6,534 total. The research and public health impact of these multicenter 
collaborative projects initiated by CPCRN during that 10-year period were then examined. 
CPCRN established numerous workgroups around topics such as: 2-1-1, training and technical 
assistance, colorectal cancer control, federally qualified health centers, cancer survivorship, and 
human papillomavirus. The paper discusses the challenges that arise in promoting multicenter 
collaboration and the strategies that CPCRN uses to address those challenges. The lessons learned 
should broadly interest those seeking to promote multisite collaboration to address public health 
problems, such as cancer prevention and control.
Introduction
Despite significant advances in the prevention, detection, and treatment of cancer over the 
past 25 years, cancer-related morbidity and mortality remains stubbornly high, especially 
among racial/ethnic minorities and other vulnerable populations.1 In 2016, an estimated 
1,685,210 Americans will receive a cancer diagnosis and 595,690 will die of cancer.1
To reduce this burden, the Centers for Disease Control and Prevention (CDC) in conjunction 
with the National Cancer Institute (NCI) initiated the Cancer Prevention and Control 
Research Network (CPCRN), a national network of academic, public health, and community 
partners that, since 2002, has conducted community-based research to2,3:
1. accelerate the adoption and implementation of evidence-based cancer prevention 
and control; and
2. enhance large-scale efforts to reach underserved populations.
The CPCRN works with national, state, and local partners to reduce cancer risk, improve 
screening utilization, reduce cancer death, and mitigate health disparities by advancing the 
science and practice of dissemination and implementation. Over four cycles of funding, 
CPCRN has included between three and ten Collaborating Centers (Table 1). Presently, 
CPCRN consists of a Coordinating Center, Collaborating Centers, and hundreds of 
investigators representing disciplines including epidemiology, health behavior, medicine, 
nursing, nutrition, psychology, and sociology.
As a “network of networks,” CPCRN operates at two levels. Each Collaborating Center 
conducts its own research projects in collaboration with state and local partners, but also 
conducts multicenter research projects with state and national partners. This dual focus 
distinguishes CPCRN from many federally funded research networks in which multicenter 
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collaboration is often limited to information sharing or data coordination across locally 
implemented research projects. Although multicenter collaboration is encouraged in 
federally funded research networks, it is challenging to promote, as Collaborating Centers 
have a dual focus of focusing their attention and resources on their own center projects, as 
well working on network projects.
This article describes the CPCRN’s multicenter collaborative research projects and their 
accomplishments, documents the growth of multicenter collaboration within CPCRN over a 
10- year period, and discusses strategies that CPCRN has used to promote multicenter 
collaboration. It concludes with recommendations for other multicenter research initiatives.
Methods
A retrospective, longitudinal, descriptive design was used to analyze existing administrative 
and bibliographic data on cross-center collaborations.
The CPCRN employs an online reporting system to monitor and evaluate network activities 
and outcomes by collecting detailed information from Collaborating Centers twice yearly 
about individual-center and multicenter research activity, grant applications, publications, 
and presentations. The reporting system also collects narrative data on goals and 
accomplishments. To assess the growth of multicenter publications, authorship data from 
three bibliographic databases (PubMed, Scopus, and Web of Science) were collected for 309 
unique CPCRN researchers identified in the CPCRN administrative database, using 
researchers’ first initial and last name (PubMed and Web of Science) or Author ID (Scopus) 
and site-specific geographic identifiers. Searches were limited to the years 2004–2014. 
Bibliographic records were managed in EndNote 6.0. Duplicate and false positive records 
were removed. Author-level data were extracted across: all publications and multisite papers. 
Records for Medical Subject Heading term extraction were searched and downloaded on 
October 29, 2014.
To document the growth of multicenter collaboration, the number of multicenter grant 
applications submitted and funded and the number of peer-reviewed journal articles 
published per year from 2004 to 2014 were counted. Both the total number of publications 
per CPCRN author by site and total number of multicenter publications are listed. Grant 
applications and articles were considered “multicenter” if they involved investigators from 
two or more centers. A co-authorship network analysis of multicenter publications was also 
conducted. Each record was assigned a center-level identifier and linked with unique article-
level identifiers to construct co-authorship networks for each year. Custom Python scripts, R, 
version 3.0.2, and Excel were used to parse, process, and summarize data; Pajek, version 
3.14 was used to visualize networks.
Results
Cancer Prevention and Control Research Network Multi-Center Workgroups
Since its inception, CPCRN has sponsored many multicenter workgroups. Five of the most 
productive ones are highlighted here.
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2-1-1 workgroup. 2-1-1 is a nationally designated three-digit telephone information and 
referral service that connects callers to local health and social services.4 These callers 
represent individuals with many basic needs and who are at increased risk for cancer and 
other chronic diseases based on their high rates of unemployment, low levels of income and 
education,5 and African American or Hispanic race/ethnicity.
The workgroup’s early studies demonstrated that 2-1-1 callers had lower rates of cancer 
screening and higher rates of smoking than U.S. adults7 and showed that 2-1-1 callers were 
willing to complete a brief cancer risk assessment and accept referrals for cancer control 
services.6 This work was highlighted in a Supplement to the American Journal of Preventive 
Medicine, “Research Collaboration with 2-1-1 to Eliminate Health Disparities.”7 Later 
studies tested interventions among 2-1-1 callers, demonstrating the effectiveness of using 
proactive referrals and phone navigation to connect callers with cancer control services.8 In 
an NCI-funded study, CPCRN researchers developed an intervention to promote smoke-free 
home policies to 2-1-1 callers and tested it in an initial efficacy trial in Atlanta and two 
effectiveness trials in North Carolina and Houston; all demonstrated intervention 
effectiveness,9 and the intervention is currently being disseminated to 2,410 people at 2-1-1s 
in Akron, Cleveland, Orlando, Tulsa, and Alabama. The team is also adapting and testing 
Spanish and Chinese versions.
Training and technical assistance. Building community and other partners’ capacity to use 
evidence-based approaches has been an enduring focus of the CPCRN. This work is 
grounded in the Interactive Systems Framework for Dissemination and Implementation of 
Wandersman et al.2,10 CPCRN members from eight centers conducted formative research on 
cancer control planners’ capacity to use evidence-based approaches,11 which evolved into 
the Capacity-Building Technical Assistance and Training workgroup that developed the 
Putting Public Health Evidence in Action curriculum and facilitator’s guide delivered in 14 
workshops to >600 practitioners nationwide (http://cpcrn.org/pub/evidence-in-action/). 
Multiple centers have built on the workgroup’s curriculum to deliver and test local capacity-
building interventions.12–14 Workgroup members collaborated a literature review to guide 
the design of capacity-building interventions15,16 and collaborated on an NCI grant 
(4R01CA163526-05) to develop and test an online tool (IM Adapt) based on Intervention 
Mapping framework17 that guides practitioners through a systematic process of selecting 
and adapting evidence-based interventions (EBIs) to fit their local community and context.18 
This project formed an advisory group with representatives from multiple CPCRN sites and 
is being beta tested.
Colorectal Cancer Control Program. In 2009, the CDC Colorectal Cancer Control Program 
(CRCCP) awarded a 5-year cooperative agreement to 25 states and four tribal organizations 
to increase population-level screening rates to 80% in participating states and tribes and, 
consequently, to reduce CRC incidence and mortality (www.cdc.gov/cancer/crccp/). CPCRN 
partnered with CDC to evaluate grantees’ use of EBIs recommended in the Guide to 
Community Preventive Services (www.thecommunityguide.org/cancer/index.html).
The workgroup led development and implementation of an annual CRCCP grantee survey 
starting in 2011 to measure EBI implementation; this survey was one component of the 
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CRCCP evaluation. Grantees used more EBIs over time, and generally used more client-
oriented than provider-oriented EBIs. CRCCP evaluation findings led to significant changes 
in the program structure for 2015–2020.19–21 CDC now requires all CRCCP grantees to 
partner with healthcare systems to implement EBIs. Future directions include collaborating 
with CDC to evaluate partner healthcare systems’ implementation of EBIs and their impact 
on patients’ CRC screening rates with a goal of implementing more provider-oriented EBIs.
Federally qualified health centers. CPCRN members partnered with federally qualified 
health centers (FQHCs) and state and national partners including primary care associations 
to advance the dissemination and implementation of cancer prevention and control programs 
with a focus on underserved populations.
The Practice Change and Development Model22 and the Consolidated Framework for 
Implementation Research23 guided development of a survey that was administered to 
FQHCs in seven states to develop and test measures and to assess correlates of 
implementation of evidence-based strategies to increase colorectal cancer screening. 
Analyses to assess the validity and reliability of the Consolidated Framework for 
Implementation Research measures found they have structural validity, reliability, 
discriminant validity, and can be aggregated to the clinic level. Also, clinics within systems 
have more similar values for inner-setting domain constructs than clinics in different 
systems.24 FQHCs implemented CDC-recommended evidence-based approaches at varying 
levels, which ranged from 30% to almost 60% implementing at least one evidence-based 
approach for increasing colorectal cancer screening. Results also showed higher Adaptive 
Reserve, as measured by the Practice Adaptive Reserve score,25,26 is positively associated 
with implementation of Patient-Centered Medical Home colorectal cancer screening best 
practices by clinic staff. Poor electronic health record data quality and cumbersome systems 
may be significant barriers to implementation of evidence-based practices; most FQHCs 
reported that using electronic health record systems to measure and improve colorectal 
cancer screening was challenging.
The FQHC workgroup also conducted five focus groups and 21 in-person interviews with 
FQHC leaders in 14 states in a qualitative study of factors affecting implementation of 
evidence-based cancer control practices. FQHC leaders identified successes and barriers to 
implementing cancer control practice change in their clinics. Factors contributing to 
successful implementation included the ability to:
1. identify leaders, champions, facilitators, and implementers to play key roles;
2. offer training and capacity-building activities to motivate staff and gain buy-in;
3. provide staff incentives and rewards; and
4. incorporate systemization, auditing, and feedback into implementing practice 
change.
External factors such as insufficient organizational resources, limited networks, and patients’ 
influences negatively influenced implementation.27
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Cancer survivorship. As advancements in early detection and treatment continue, there are 
>13 million survivors alive today in the U.S., with an estimated 18 million at the end of the 
decade.1 The Survivorship workgroup identified and facilitated opportunities to promote the 
translation and dissemination of evidence-based practices in cancer survivorship.
The Survivorship workgroup documented health promotion programs for cancer survivors in 
four states,28 using the Reach Adoption, Implementation, and Maintenance (RE-AIM) 
framework as a guide.29 Data on program reach described a dearth of programs in rural 
areas. Program implementation data showed that psychosocial and physical activity 
programs were most commonly offered, whereas nutrition and weight management 
programs were offered less frequently, if at all. Cancer control planners in three of the 
participating states used the survey results to illustrate the opportunity to link research and 
public health practice.
The Survivorship workgroup identified self-management support interventions, such as the 
Chronic Disease Self-Management Program as a potential strategy toward improving 
outcomes in other chronic conditions, but one that has yet to be widely applied to cancer 
survivorship in practice. Workgroup members implemented the adapted program for use 
with cancer survivors and tested its effectiveness in an RCT. Results support effectiveness in 
survivors, with effect sizes similar to those observed in other chronic disease populations, 
regardless of cancer type.30 Based on the evidence from this collaborative work, the Chronic 
Disease Self-Management Program developers at Stanford now offer an adapted version for 
cancer survivors. Taken together, these research activities used key dissemination and 
implementation science to facilitate the translation of EBIs to cancer survivors.
Human papillomavirus vaccine. The U.S. Food and Drug Administration approved human 
papillomavirus (HPV) vaccination for adolescents and young adults nearly a decade ago. 
However, HPV vaccine uptake and completion of the three-dose vaccine series has been 
suboptimal. CPCRN identified promotion of HPV vaccination as an emerging public health 
issue shortly after the vaccine was first approved and formed its HPV vaccine workgroup.
Projects included development and cognitive testing of survey items that represent constructs 
known to affect vaccine acceptability and completion,31 and summarization of measures of 
HPV vaccine knowledge, attitudes, beliefs, and acceptability, describing their psychometric 
characteristics.32 These two projects provided valuable information on measures for 
assessing factors associated with HPV vaccination and evaluating the success of efforts to 
promote its use.
The CPCRN sites that focus on Latino populations conducted a survey to assess HPV 
vaccine initiation and correlates of initiation among Latina adolescent girls. Data were 
collected from caregivers of 444 girls in California (Los Angeles County), Washington 
(Yakima Valley), and Texas (Houston and Lower Rio Grande Valley). Low uptake of the 
vaccine (26%–37%) was documented across regions. Observed regional similarities and 
differences have been used to inform the implementation of HPV vaccination programs in 
Latino communities and healthcare systems serving Latino patients.33 CPCRN sites 
developed an interactive application delivered via iPads that proved to be effective in 
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increasing HPV vaccination in Latina girls in Houston,34 and are evaluating an organization-
level intervention to increase HPV vaccine uptake among ethnic minority adolescents in Los 
Angeles.
Growth of multicenter collaboration. The CPCRN investigators have been highly successful 
in leveraging their Collaborating Center funding to advance research in the adoption and 
implementation of evidence-based cancer prevention and control. Since 2004, CPCRN 
investigators have received 513 grants for their cancer control work, exceeding $484 million. 
Of the 513 grants, 42 were multicenter grants, exceeding $59 million. The number of 
multicenter grants rose steadily over time (Figure 1).
The CPCRN members also have been highly prolific contributors to the scientific literature 
on evidence-based cancer prevention and control. From 2004 to 2014, CPCRN investigators 
have published 6,534 articles, including 249 multicenter CPCRN publications. The number 
of multicenter publications rose steadily over time (Figure 2). Collaborating Centers 
participated in an average of 2.3 multicenter scientific articles per Collaborating Center 
author, with some Collaborating Centers participating in more multicenter publications than 
others (Table 1).
Most of CPCRN’s multicenter publications focused on cancer prevention and control. Of the 
240 multicenter publications indexed in PubMed, 164 (68.3%) matched keyword searches 
for Medical Subject Heading cancer terms (Figure 2). The six most frequently occurring 
topical Medical Subject Heading terms assigned to multicenter publications overall were 
Mass Screening (38%), Neoplasms (35%), Health Knowledge, Attitudes, Practice (26%), 
Colorectal Neoplasms (25%), Breast Neoplasms (18%), and Health Promotion (17%).
Co-authorship network analysis indicates that the density of multicenter collaboration on 
scientific publications grew over time. In network analysis, density indicates the 
connectedness of nodes in a network (i.e., Collaborating Centers in CPCRN) and was 
measured by counting the number of ties that are present out of the total possible number of 
ties: A density of 1 would indicate that each center collaborated with every other center, and 
a density of 0 would indicate no collaboration among centers occurred. From 2004 to 2014, 
the density of the CPCRN collaboration network grew from 0.18 to 0.93. The greatest 
increases occurred immediately after new centers joined CPCRN: After Emory, Morehouse, 
University of California, Los Angeles, University of North Carolina, and Washington 
University in St. Louis joined CPCRN in 2004, network density increased from 0.18 to 0.33 
in 2005, and to 0.49 in 2006. After Central Texas, Colorado, and University of South 
Carolina joined in 2009, density increased from 0.58 in 2009 to 0.73 in 2010. In other years, 
increases in network density were much lower (range, 0.02–0.07; mean, 0.04). In summary, 
this analysis clearly shows a pattern of more extensive collaboration between member 
centers over time.
Challenges and Lessons Learned
This paper describes the key accomplishments of CPCRN in advancing collaborative 
research in cancer prevention and control. The analysis of multicenter grants and 
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publications showed increased collaborations between centers each year. Over time, all 
centers were engaged in collaborations with other centers and in several cases the entire 
network collaborated on projects. Achieving collaboration is important, but not the end goal. 
The main goal was to advance the science in key areas related to the CPCRN mission. Yet, it 
was through multicenter collaboration that the CPCRN leveraged the expertise, resources, 
and partnerships of participating centers and conducted research projects that had an impact 
beyond what individual centers could have achieved on their own. One of the biggest 
challenges faced was generating collaborations given that CPCRN involved hundreds of 
investigators located across a wide geographic distance. Another challenge was vetting new 
ideas given that investigators had lots of ideas and were often strongly attached to them.
The level of multicenter collaboration, and the impact that multicenter projects achieved, 
was due in no small part to the ideas, expertise, energy, and commitment of the investigators 
that CPCRN attracted. Yet, multicenter collaboration was no fortuitous accident. CDC built 
multicenter collaboration into the design of CPCRN by explicitly stating in its Request for 
Applications that Collaborating Centers were expected to generate and commit resources to 
multicenter collaborative projects. CDC and NCI program officers reinforced this 
expectation through their active participation in monthly CPCRN Steering Committee calls 
and annual meetings; their ongoing participation in cross-center project conference calls also 
underscored the importance of progress, productivity, and impact through multicenter 
collaboration.
In addition, the CPCRN Coordinating Center created processes and developed resources to 
support multicenter communication, coordination, and provided logistic support and 
research services to support multicenter collaboration. For example, the Coordinating Center 
formulated a set of principles, processes, and criteria to facilitate the identification, vetting, 
and selection of cross-center project ideas. Priority was given to workgroup ideas that had 
clear deliverables— typically one or more manuscripts, a grant application, or development 
of an intervention. Ideas that had been piloted at one local center were often more successful 
as multicenter projects because they could be readily adapted elsewhere through sharing of 
materials such as IRB applications, protocols, and survey measures. The Coordinating 
Center facilitated collaboration by supplying toll-free conference lines, web conferencing 
software, and website resources including an online calendar listing conference call 
schedules; an online directory of network members and “e-mail workgroups” function; and 
online collaboration tools with sophisticated features.
Research services included scientific consultation on project ideas; review of grant 
proposals; development of IRB templates; development of online surveys; and feedback on 
manuscripts, reports, and presentations. Importantly, the Coordinating Center developed an 
online reporting system that collected detailed information about every cancer plan or policy, 
research activity, grant application, publication, and presentation by Collaborating Centers 
and workgroups. The Coordinating Center, Steering Committee, and the funders used these 
data to monitor performance with particular attention focused on multicenter collaboration.
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Conclusions
In conclusion, CPCRN has flourished by building a strong infrastructure35 needed for 
collaboration and addressing timely and important cancer control topics. Many challenges 
still remain in addressing cancer disparities, and this will continue to be a focus of the 
network going forward.
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Figure 1. 
Multi-center collaboration in grants.
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Figure 2. 
Multi-center collaboration in scientific publication.
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Figure 3. 
Cumulative collaborations between CPCRN member sites, 2004–2014.
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